AU565087B2 - 1,4-dihydro-4-oxonaphthyridine derivatives - Google Patents
1,4-dihydro-4-oxonaphthyridine derivativesInfo
- Publication number
- AU565087B2 AU565087B2 AU41650/85A AU4165085A AU565087B2 AU 565087 B2 AU565087 B2 AU 565087B2 AU 41650/85 A AU41650/85 A AU 41650/85A AU 4165085 A AU4165085 A AU 4165085A AU 565087 B2 AU565087 B2 AU 565087B2
- Authority
- AU
- Australia
- Prior art keywords
- dihydro
- oxonaphthyridine derivatives
- oxonaphthyridine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59-84963 | 1984-04-26 | ||
JP59084963A JPS60228479A (ja) | 1984-04-26 | 1984-04-26 | 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU81804/87A Division AU612993B2 (en) | 1984-04-26 | 1987-11-25 | 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4165085A AU4165085A (en) | 1985-10-31 |
AU565087B2 true AU565087B2 (en) | 1987-09-03 |
Family
ID=13845280
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU41650/85A Expired AU565087B2 (en) | 1984-04-26 | 1985-04-24 | 1,4-dihydro-4-oxonaphthyridine derivatives |
AU81804/87A Expired AU612993B2 (en) | 1984-04-26 | 1987-11-25 | 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU81804/87A Expired AU612993B2 (en) | 1984-04-26 | 1987-11-25 | 1,4-dihydro-4-oxonaphthyridine derivatives and salts thereof, process for producing the same and antibacterial agents comprising the same |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS60228479A (es) |
KR (1) | KR870001693B1 (es) |
AR (1) | AR241911A1 (es) |
AT (2) | AT389698B (es) |
AU (2) | AU565087B2 (es) |
BE (1) | BE902279A (es) |
CH (1) | CH673458A5 (es) |
CS (1) | CS250684B2 (es) |
DD (1) | DD238795A5 (es) |
DE (2) | DE3546658C2 (es) |
DK (1) | DK165877C (es) |
EG (1) | EG17339A (es) |
ES (2) | ES8700256A1 (es) |
FI (1) | FI80453C (es) |
FR (2) | FR2563521B1 (es) |
GB (2) | GB2158825B (es) |
HU (2) | HU194226B (es) |
ID (1) | ID21142A (es) |
IL (1) | IL75021A (es) |
IT (1) | IT1209953B (es) |
LU (1) | LU85871A1 (es) |
NL (2) | NL187314C (es) |
NO (1) | NO162238C (es) |
NZ (1) | NZ211895A (es) |
PH (3) | PH22801A (es) |
PL (1) | PL147392B1 (es) |
PT (1) | PT80349B (es) |
RO (2) | RO95509B (es) |
SE (2) | SE463102B (es) |
ZA (1) | ZA853102B (es) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU576657B2 (en) * | 1985-01-23 | 1988-09-01 | Toyama Chemical Co. Ltd. | Naphthyridine and pyridine derivatives |
AU589978B2 (en) * | 1985-06-26 | 1989-10-26 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6172753A (ja) * | 1984-09-18 | 1986-04-14 | Dainippon Pharmaceut Co Ltd | ピリジルケトン誘導体 |
AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
DE3525108A1 (de) * | 1985-06-07 | 1986-12-11 | Bayer Ag, 5090 Leverkusen | Antibakteriell wirksame chinoloncarbonsaeureester |
IE62600B1 (en) * | 1987-08-04 | 1995-02-22 | Abbott Lab | Naphtyridine antianaerobic compounds |
US4962112A (en) * | 1987-08-04 | 1990-10-09 | Abbott Laboratories | 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds |
US4859776A (en) * | 1988-03-11 | 1989-08-22 | Abbott Laboratories | (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation |
JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
DE3934082A1 (de) * | 1989-10-12 | 1991-04-18 | Bayer Ag | Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel |
AU1161492A (en) * | 1991-01-14 | 1992-08-17 | Hanmi Pharmaceutical Co., Ltd. | Novel quinolone compounds and processes for preparation thereof |
FR2692577B1 (fr) * | 1992-05-26 | 1996-02-02 | Bouchara Sa | Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant. |
KR940014395A (ko) * | 1992-12-09 | 1994-07-18 | 강박광 | 신규한 퀴놀론 유도체 및 그의 제조방법 |
KR0148277B1 (ko) * | 1993-01-18 | 1998-11-02 | 채영복 | 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법 |
WO1994025464A1 (en) * | 1993-04-24 | 1994-11-10 | Korea Research Institute Of Chemical Technology | Novel quinolone carboxylic acid derivatives and process for preparing the same |
KR950018003A (ko) * | 1993-12-09 | 1995-07-22 | 스미스클라인 비참 피엘씨 | 신규한 퀴놀론 유도체 및 그의 제조 방법 |
US5910498A (en) * | 1994-10-20 | 1999-06-08 | Wakunaga Seiyaku Kabushiki Kaisha | Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient |
DE69729565T2 (de) | 1996-04-19 | 2005-06-09 | Wakunaga Pharmaceutical Co., Ltd. | Neue Pyridoncarbonsäure-Derivate oder Salze dieser Derivate und antibakterielle Mittel, die diese aktiven Wirkstoffe enthalten |
KR20000052892A (ko) * | 1996-10-30 | 2000-08-25 | 빌프리더 하이더 | 나프티리딘 화합물의 제조 방법 및 신규 중간 생성물 |
DE19713506A1 (de) | 1997-04-01 | 1998-10-08 | Bayer Ag | Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere |
JP4694669B2 (ja) | 1999-03-17 | 2011-06-08 | 第一三共株式会社 | 医薬組成物 |
US6441182B1 (en) | 1999-06-10 | 2002-08-27 | Bayer Aktiengesellschaft | Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid |
MXPA02002220A (es) | 1999-09-02 | 2002-09-02 | Wakunaga Pharma Co Ltd | Derivados de acido quinolincarboxilico o su sal. |
EP1313708A1 (en) * | 2000-08-29 | 2003-05-28 | Chiron Corporation | Quinoline antibacterial compounds and methods of use thereof |
KR100981351B1 (ko) * | 2003-10-29 | 2010-09-10 | 주식회사 엘지생명과학 | 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법 |
CN101792443A (zh) * | 2010-03-09 | 2010-08-04 | 北京欧凯纳斯科技有限公司 | 氟代喹诺酮衍生物及其制备方法和用途 |
JOP20190045A1 (ar) | 2016-09-14 | 2019-03-14 | Bayer Ag | مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها. |
CN114369092A (zh) * | 2021-12-20 | 2022-04-19 | 赤峰万泽药业股份有限公司 | 甲苯磺酸妥舒沙星及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2125310A1 (en) * | 1971-05-21 | 1972-11-30 | Sterling Drug Inc , New York, NY (V St A) | 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac |
AR223983A1 (es) * | 1978-08-25 | 1981-10-15 | Dainippon Pharmaceutical Co | Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico |
DE3033157A1 (de) * | 1980-09-03 | 1982-04-01 | Bayer Ag, 5090 Leverkusen | 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel |
US4382937A (en) * | 1981-02-27 | 1983-05-10 | Dainippon Pharmaceutical Co., Ltd. | Naphthyridine derivatives and their use as anti-bacterials |
IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
NZ210847A (en) * | 1984-01-26 | 1988-02-29 | Abbott Lab | Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions |
IL74064A (en) * | 1984-01-26 | 1988-09-30 | Abbott Lab | 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them |
AU576657B2 (en) * | 1985-01-23 | 1988-09-01 | Toyama Chemical Co. Ltd. | Naphthyridine and pyridine derivatives |
DE3525108A1 (de) * | 1985-06-07 | 1986-12-11 | Bayer Ag, 5090 Leverkusen | Antibakteriell wirksame chinoloncarbonsaeureester |
-
1984
- 1984-04-26 JP JP59084963A patent/JPS60228479A/ja active Granted
-
1985
- 1985-04-18 DE DE3546658A patent/DE3546658C2/de not_active Expired - Lifetime
- 1985-04-18 DE DE19853514076 patent/DE3514076A1/de active Granted
- 1985-04-23 PH PH32174A patent/PH22801A/en unknown
- 1985-04-23 GB GB08510297A patent/GB2158825B/en not_active Expired
- 1985-04-23 NL NLAANVRAGE8501172,A patent/NL187314C/xx not_active IP Right Cessation
- 1985-04-24 RO RO126286A patent/RO95509B/ro unknown
- 1985-04-24 IL IL7502185A patent/IL75021A/en not_active IP Right Cessation
- 1985-04-24 NZ NZ211895A patent/NZ211895A/xx unknown
- 1985-04-24 RO RO118517A patent/RO91871B/ro unknown
- 1985-04-24 AU AU41650/85A patent/AU565087B2/en not_active Expired
- 1985-04-24 AT AT0122485A patent/AT389698B/de not_active IP Right Cessation
- 1985-04-24 DD DD85275518A patent/DD238795A5/de unknown
- 1985-04-24 EG EG261/85A patent/EG17339A/xx active
- 1985-04-24 NO NO851643A patent/NO162238C/no not_active IP Right Cessation
- 1985-04-24 PT PT80349A patent/PT80349B/pt unknown
- 1985-04-25 HU HU851599A patent/HU194226B/hu unknown
- 1985-04-25 ES ES542584A patent/ES8700256A1/es not_active Expired
- 1985-04-25 AR AR85300190A patent/AR241911A1/es active
- 1985-04-25 FI FI851637A patent/FI80453C/fi not_active IP Right Cessation
- 1985-04-25 ID IDP980525A patent/ID21142A/id unknown
- 1985-04-25 ZA ZA853102A patent/ZA853102B/xx unknown
- 1985-04-25 FR FR858506327A patent/FR2563521B1/fr not_active Expired
- 1985-04-25 KR KR1019850002822A patent/KR870001693B1/ko not_active IP Right Cessation
- 1985-04-25 BE BE0/214909A patent/BE902279A/fr not_active IP Right Cessation
- 1985-04-25 HU HU873675A patent/HU197571B/hu unknown
- 1985-04-25 CH CH1798/85A patent/CH673458A5/de not_active IP Right Cessation
- 1985-04-25 DK DK185685A patent/DK165877C/da not_active IP Right Cessation
- 1985-04-25 CS CS853035A patent/CS250684B2/cs not_active IP Right Cessation
- 1985-04-25 SE SE8502017A patent/SE463102B/sv not_active IP Right Cessation
- 1985-04-26 IT IT8548002A patent/IT1209953B/it active
- 1985-04-26 LU LU85871A patent/LU85871A1/en unknown
- 1985-04-26 PL PL1985253108A patent/PL147392B1/pl unknown
-
1986
- 1986-01-31 ES ES551538A patent/ES8706673A1/es not_active Expired
-
1987
- 1987-07-17 GB GB8716897A patent/GB2191776B/en not_active Expired - Lifetime
- 1987-10-20 PH PH35958A patent/PH25046A/en unknown
- 1987-10-20 PH PH35960A patent/PH25228A/en unknown
- 1987-11-25 AU AU81804/87A patent/AU612993B2/en not_active Expired
-
1988
- 1988-06-30 FR FR888808836A patent/FR2614620B1/fr not_active Expired - Lifetime
- 1988-10-31 AT AT0267888A patent/AT390258B/de not_active IP Right Cessation
- 1988-12-20 SE SE8804586A patent/SE501412C2/sv not_active IP Right Cessation
-
1991
- 1991-04-15 NL NL9100648A patent/NL9100648A/nl not_active Application Discontinuation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU576657B2 (en) * | 1985-01-23 | 1988-09-01 | Toyama Chemical Co. Ltd. | Naphthyridine and pyridine derivatives |
AU589978B2 (en) * | 1985-06-26 | 1989-10-26 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2153821B (en) | 3-imidazolylmethyl-1,2,3,9-tetrahydro-4h-carbazol-4-one derivatives | |
AU586182B2 (en) | Analgesic 1,2-Benzisothiazol-3-ylpiperazine derivatives | |
AU565087B2 (en) | 1,4-dihydro-4-oxonaphthyridine derivatives | |
AU8065587A (en) | 3,4-dihydro-3-phenyl-2H-1-benzopyran derivatives | |
AU589931B2 (en) | 1,2,4-triazole derivatives | |
AU7368187A (en) | 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives | |
AU4744985A (en) | 1,4-dihydropyridine derivatives | |
AU566416B2 (en) | 1,8- - naphthyridine or hydroquineline derivatives | |
AU6675186A (en) | Substituted 5,6-dialkoxyquinazoline derivatives | |
AU566419B2 (en) | U/,3-oxazoliding-2-one derivatives | |
AU576279B2 (en) | 2,4-diamino-pyrimidines | |
AU576393B2 (en) | 1,2,4 - triazolo - carbamate compounds | |
AU574806B2 (en) | 2,2,6,6 - tetramethyl - 4 - piperidinyl derivatives | |
AU2956484A (en) | Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives | |
AU577140B2 (en) | 2,4-diamino-6-difluoromethylthio-1,3,5-triazine derivatives | |
EP0183975A3 (en) | 5,6,7,8-tetrafluoroanthraquinone derivatives | |
AU3808385A (en) | 1,3,2-dioxaborinanes | |
HK185395A (en) | 9,11-Epoxy-21-hydroxypregnane derivatives | |
AU7519987A (en) | 1,1,2-triaryl-1-alkene derivatives | |
AU4023085A (en) | 1,2,4-triazacycloalkadiene derivatives | |
AU577152B2 (en) | 1,4-dihidropyridine-3,5-dicarboxylate derivatives | |
AU564985B2 (en) | 1,4-aminoalkylamino-9h-thioxanthen-9-ones | |
AU4089185A (en) | 1,3-benzodioxole derivatives | |
AU4004085A (en) | 3-mercapto-1,2,4-triazacycloalkadiene derivatives | |
AU572869B2 (en) | 1,6-naphthyridin derivatives |